Santarus reps pushing Naprelan

Share this article:
Santarus said its sales reps will commence promotional activities in the third quarter for Victory Pharma's Naprelan brand products under a recent co-promotion agreement.

Naprelan tablets are a once daily control-release formulation of the non-steroidal anti-
inflammatory drug (NSAID) naproxen sodium, indicated for pain relief caused by a number of conditions including arthritis.

Santarus said it plans to promote Naprelan to targeted primary care physicians. Reps will also continue to promote the company's Rx heartburn treatment Zegerid to gastroenterologists and primary care doctors alongside reps from inVentiv and Otsuka America.  

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.